Tissuemed® is pleased to announce that the TissuePatch product family of surgical sealant films including TissuePatch™ and TissuePatchDural™ has received regulatory of approval by the Iranian Ministry of Health.
Dr David Mandley Tissuemed’s CEO commented: “We are thrilled by this latest news from the region and thank our local distributor in Iran for their excellent support and commitment in working to secure these registrations. With a population of approaching 80 million – one of the largest in the Middle East, and an advanced healthcare system, Iran represents an excellent market with enormous potential for Tissuemed® and our innovative range of surgical sealants.”